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A 59-year-old male with an secundum atrial septal defect status post repair with an
Amplatzer occluder in 2001 was admitted with sepsis and MRSA bacteremia. Trans-
esophageal Echocardiography (TEE) showed presence of an overlying mobile echogenic
structure on the left atrial surface of the device suggestive of a vegetation/infected
thrombus. This is only the 3rd case description of late endocarditis involving the Amplatzer
ASD closure device in an adult.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Case description Supplementary video related to this article can be found atA 59-year-old male with a history of hypertension, type 2
diabetes, Congestive heart failure s/p Implantable Car-
dioverter Defibrillator and a Secundum ASD s/p percutaneous
repair with an Amplatzer Atrial Septal Occluder Device (ASO;
AGA Medical Corporation, Golden Valley, Minnesota) was
admitted with sepsis and positive blood cultures for MRSA.
Bacteremia persisted despite IV Vancomycin. With a high
suspicion for Infective endocarditis (IE) despite normal
Transthoracic echocardiography, a TEE was done. It showed a
highly mobile echogenic mass suggestive of vegetation/
infected thrombus in the left atrial surface of the device Figs. 1
and 2, Videos 1 and 2. After initiation of IV daptomycin, there
was significant clinical improvement leading to discharge
with 6 weeks of IV antibiotic.eet, Apt 908, Chicago, IL
ealth.com (B. Aruni).
2013, Cardiological Sociehttp://dx.doi.org/10.1016/j.ihj.2013.06.002.2. Comments
The Amplatzer septal occluder is one of the most frequently
used percutaneous devices for the closure of SecundumASD.1
Complications of this procedure include device embolization/
malposition, arrhythmias, cardiac perforation, thrombus for-
mation and device erosion with infection being the least
common.2
Only 2 previous cases of late infection of occluder device
have been reported in literature.3e5 A case of IE involving a
CardioSEAL device for patent foramen ovale has also been60657, USA. Tel.: þ1 312 547 0499; fax: þ1 773 296 7486.
ty of India. All rights reserved.
Fig. 1 e Zoomed 30 transesophageal short axis view of the
interatrial septum with Amplatzer device and vegetation.
Bold red arrow e Vegetation; Bold blue arrow e Amplatzer
septal occluder LA e Left atrium; RA e Right atrium.
Fig. 2 e 60 Transesophageal short axis view of the
interatrial septum with Amplatzer device and vegetation.
Bold red arrow e Vegetation; Bold blue arrow e Amplatzer
septal occluder LA e Left atrium; RA e Right atrium.
i n d i a n h e a r t j o u rn a l 6 5 ( 2 0 1 3 ) 4 5 0e4 5 1 451described.6 Device infection can occur in two ways; either
through introduction of microbes during the procedure or
secondary to seeding of microorganisms at a later time. After
device implantation, it is thought that it takes 6 months forcomplete neoendothelialization. The current guidelines
recommend antibiotic prophylaxis for 6 months following
device placement.7 The organism isolated in this case is
classical for nosocomial infection, likely from infection from
an abdominal wound.
In late IE involving ASD closure device medical manage-
ment with prolonged antibiotic therapy with constant blood
culturemonitoringmight be adequate in the absence of device
dehiscence, septal perforation or fistula formation.Conflicts of interest
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